EPA & DHA Market Size, Share, Global Industry Overview, Opportunity and Forecast 2024-2032

IMARC Group, a leading market research company, has recently releases report titled “EPA & DHA Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” The study provides a detailed analysis of the industry, including the global EPA & DHA market trends, size, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the EPA & DHA market?

The global EPA & DHA market size reached USD 1,877.4 Million in 2023. Looking forward, IMARC Group expects the market to reach USD 3,228.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.

Factors Affecting the Growth of the EPA & DHA Industry:

• Growing consumer awareness of health benefits:

Increased awareness of the health benefits associated with EPA and DHA has been a significant driver of market growth. These omega-3 fatty acids are renowned for their positive effects on cardiovascular health, cognitive function, and inflammation reduction. Research has consistently demonstrated that EPA and DHA can lower the risk of heart disease, improve brain health, and alleviate symptoms of various inflammatory conditions. This growing body of evidence has led to a heightened consumer focus on maintaining a healthy lifestyle through dietary choices. As health-conscious individuals seek to optimize their well-being, they increasingly turn to supplements and foods fortified with EPA and DHA. Media coverage, health campaigns, and scientific studies continue to educate the public, further driving the demand for these omega-3s.

• Rising demand for functional foods and supplements:

The increasing interest in functional foods and dietary supplements is another major driver of the EPA and DHA market. Functional foods, which provide health benefits beyond basic nutrition, have gained popularity as consumers seek products that offer specific health advantages. EPA and DHA, often found in fish oil and algae-based supplements, are prominent in this category. These supplements are marketed for their potential to support heart health, improve mental acuity, and enhance overall well-being. Additionally, the growth of the global supplement market, driven by trends in preventive healthcare and personalized nutrition, has heightened the demand for omega-3 supplements. The expansion of the functional food sector, including fortified beverages and snacks, has also contributed to the increased availability and consumption of EPA and DHA.

• Increasing applications in pharmaceutical and dietary supplement industries:

The pharmaceutical and dietary supplement industries are significant contributors to the growth of the EPA and DHA market. In pharmaceuticals, these omega-3 fatty acids are used in the formulation of treatments for various conditions, including cardiovascular diseases, depression, and autoimmune disorders. The development of novel drug formulations and therapies incorporating EPA and DHA has expanded their application beyond traditional supplements. Additionally, the dietary supplement industry continues to innovate with new products that leverage the benefits of EPA and DHA, such as specialized formulations for different age groups and health needs. This ongoing innovation and the broadening of product offerings within the pharmaceutical and supplement markets drive the demand for high-quality EPA and DHA sources.

Request for a sample copy of this report: https://www.imarcgroup.com/epa-dha-market/requestsample

EPA & DHA Market Report Segmentation:

Market Breakup by Type:

• Eicosapentaenoic Acid (EPA)
• Docosahexaenoic Acid (DHA)

Docosahexaenoic Acid (DHA) represented the largest segment being crucial for brain health and development.

Market Breakup by Source:

• Fish Oil
• Algae Oil
• Krill Oil
• Others

Fish oil is the primary and most common source of EPA and DHA, making it the dominant segment.

Market Breakup by Application:

• Infant Formulae
• Dietary Supplements
• Fortified Food and Beverages
• Pharmaceuticals
• Others

Dietary supplements are the most popular and widely consumed form of EPA and DHA, contributing to their largest market share.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Asia Pacific leads the market, with its rapid economic growth and increasing health awareness leading to high consumption of EPA and DHA products in the region.

Global EPA & DHA Market Trends:

The growth of the EPA & DHA market is driven by innovations in delivery systems, such as enhanced bioavailability formulations and vegan alternatives. Additionally, the rising adoption of omega-3-enriched foods by food manufacturers and increased funding for research into omega-3 benefits are fueling market expansion and diversification. Besides this, increasing regulatory support for omega-3 health claims and advancements in extraction technologies that improve product purity and efficacy are presenting lucrative opportunities for market expansion. Furthermore, heightened interest in mental health and cognitive enhancement is driving demand for these essential fatty acids in various consumer segments, thereby propelling the market forward.

Who are the key players operating in the industry?

The report covers the major market players including:

• AlgiSy BioSciences Inc.
• Arctic Nutrition AG
• BASF SE
• Biosearch Sau
• Corbion NV
• Croda International PLC
• KD Pharma Group
• Koninklijke DSM NV
• Nordic Naturals Inc
• Novasep Holding SAS
• Novotech Nutraceuticals Inc
• Omega Protein Corporation
• Polaris

Browse full report with TOC & List of Figures: https://www.imarcgroup.com/epa-dha-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145